|
Advocate Spot-on šķīdums gigantiskiem suņiem
|
-
|
EU/2/03/039/051
|
Bayer Animal Health , Vācija
|
QP54AB52
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Moxidectin,Imidacloprid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
16-Jul-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/03/039/051 |
|
1 |
Pipete, 4 ml |
-
|
|
|
Advocate Spot-on šķīdums gigantiskiem suņiem
|
-
|
EU/2/03/039/053
|
Bayer Animal Health , Vācija
|
QP54AB52
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Moxidectin,Imidacloprid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
16-Jul-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/03/039/053 |
|
9 |
Pipete, 4 ml |
-
|
|
|
Simparica Trio
|
mg
|
EU/2/19/243/003
|
Zoetis Belgium S.A., Beļģija
|
QP54AB52
|
Dogs 1,25 – 2,5 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Sarolaner, Moxidectin, Pyrantel embonate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Corden Pharma GmbH, Vācija
|
| Date of authorisation/renewal: |
17-Sep-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/243/003 |
|
6 |
Alumīnija folija blisteris, 1 tablete |
-
|
|
|
Chanaxin
|
100 mg/ml
|
EU/2/22/283/002
|
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
QJ01FA94
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Tulathromycin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
| Date of authorisation/renewal: |
19-Apr-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/22/283/002 |
100 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
|
|
Vectra 3D
|
-
|
EU/2/13/156/004
|
Ceva Sante Animale, Francija
|
QP53AC54
|
very small dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Permethrin,Pyriproxyfen,Dinotefuran
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Ceva Sante Animale, Francija
|
| Date of authorisation/renewal: |
27-Aug-2018
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/156/004 |
|
12 |
Pipete, 1 deva |
-
|
|
|
Advocate Spot-on maziem suņiem
|
-
|
EU/2/03/039/024
|
Bayer Animal Health , Vācija
|
QP54AB52
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Moxidectin,Imidacloprid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
01-Apr-2003
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/03/039/024 |
|
42 |
Pipete, 0,4 ml |
-
|
|
|
Bravecto
|
500 mg
|
EU/2/13/158/009
|
Intervet International B.V., Nīderlande
|
QP53BE02
|
medium dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet GesmbH, Austrija
|
| Date of authorisation/renewal: |
13-Feb-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/158/009 |
500 mg |
1 |
Blisteris, 4 tablete |
-
|
|
|
NexGard Combo
|
-
|
EU/2/20/267/009
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP54AA54
|
cats 2.5-7.5 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Esafoxolaner, Eprinomectin, Praziquantel
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Animal Health France SCS., Francija
|
| Date of authorisation/renewal: |
06-Jan-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/267/009 |
|
15 |
Aplikators, 0,9 ml |
-
|
|
|
DRAXXIN
|
25 mg/ml
|
EU/2/03/041/007
|
Zoetis Belgium S.A., Beļģija
|
QJ01FA94
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Tulathromycin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
23-Sep-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/03/041/007 |
25 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
|
|
OSURNIA
|
-
|
EU/2/14/170/004
|
Dechra Regulatory B.V., Nīderlande
|
QS02CA90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
gel for local use
|
| International name (active substance): |
Betamethasone,Florfenicol,Betamethasone acetate,Terbinafine
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
GENERA Inc., Horvātija;Argenta Dundee Limited, Lielbritānija
|
| Date of authorisation/renewal: |
17-Aug-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/170/004 |
|
40 |
Tūbiņa, 2,05 g |
-
|
|
|
Nobilis Multriva IBm+ND
|
-
|
EU/2/25/342/002
|
Intervet International B.V., Nīderlande
|
QI01AA10
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
02-Jun-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/342/002 |
|
1 |
PET pudele, 600 ml |
-
|
|
|
Profender tablets for medium dogs
|
-
|
EU/2/05/054/026
|
Vetoquinol S.A., Francija
|
QP52AA51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
modified-release tablets
|
| International name (active substance): |
Praziquantel,Emodepside
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
29-Jul-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/05/054/026 |
50 mg/10 mg |
24 |
Alumīnija blisteris, 1 tablete |
-
|
|
|
Emepax 60 mg
|
60 mg
|
EU/2/26/363/009
|
Axience, Francija
|
QA04AD90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Maropitant citrate monohydrate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
26-Mar-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/26/363/009 |
|
5 |
OPA/Al/PVH-Al blisteris, 4 tablete |
-
|
|
|
Prac-tic
|
137.5 mg
|
EU/2/06/066/004
|
Elanco GmbH, Vācija
|
QP53AX26
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Pyriprole
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
16-Nov-2011
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/06/066/004 |
137,5 mg/deva |
3 |
Pipete, 1 deva |
-
|
|
|
Stronghold
|
15 mg
|
EU/2/99/014/012
|
Zoetis Belgium S.A., Beļģija
|
QP54AA05
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Selamectin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Pfizer Service Company bvba, Beļģija
|
| Date of authorisation/renewal: |
01-Oct-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/99/014/012 |
15 mg/deva |
15 |
Polipropilēna tūbiņa, 1 deva |
-
|
|
|
FRONTPRO
|
136 mg
|
EU/2/19/240/015
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP53BE01
|
Dogs >25–50 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Afoxolaner
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
20-May-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/240/015 |
136 mg |
1 |
PVH/Aclar/Al blisteris, 6 tablete |
-
|
|
|
Inflacam
|
20 mg/ml
|
EU/2/11/134/005
|
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
QM01AC06
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
| Date of authorisation/renewal: |
09-Nov-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/11/134/005 |
20 mg/ml |
1 |
Flakons, 20 ml |
-
|
|
|
Onsior
|
20 mg/ml
|
EU/2/08/089/020
|
Elanco GmbH, Vācija
|
QM01AH91
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Robenacoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija;Vericore Ltd., Lielbritānija
|
| Date of authorisation/renewal: |
15-Dec-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/089/020 |
20 mg/ml |
1 |
Stikla pudelīte, 20 ml |
-
|
|
|
Simparica
|
10 mg/tabl.
|
EU/2/15/191/006
|
Zoetis Belgium S.A., Beļģija
|
QP53BE03
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Sarolaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
12-Aug-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/15/191/006 |
|
1 |
Al/Al blisteris, 6 tablete |
-
|
|
|
Simparica
|
10 mg/tabl.
|
EU/2/15/191/005
|
Zoetis Belgium S.A., Beļģija
|
QP53BE03
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Sarolaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
12-Aug-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/15/191/005 |
|
1 |
Al/Al blisteris, 3 tablete |
-
|
|